中国组织工程研究与临床康复2011，Vol.15Issue(22)：4028-4031,4.DOI:10.3969/j.issn.1673-8225.2011.22.010
髋关节置换后利伐沙班与低分子肝素预防下肢深静脉血栓的比较
Curative effect of rivaroxaban versus low molecular weight heparin to prevent deep venous thrombosis following total hip arthroplasty
靖光武 1叶树楠 2杨述华2
作者信息
- 1. 江汉大学附属医院骨科,湖北省武汉市,430015
- 2. 华中科技大学附属同济医学院协和医院骨科,湖北省武汉市,430022
- 折叠
摘要
Abstract
BACKGROUND: Low molecular weight heparin can obviously reduce the incidence of deep venous thrombosis (DVT) following total hip arthroplasty (THA). However, subcutaneous injection limits the application of low molecular weight heparin.OBJECTIVE: To observe the clinical effects and security of low molecular weight heparin and rivaroxaban against DVT after THA.METHODS: Totally 58 THA patients were randomized into two groups: rivaroxaban group with 28 cases and heparin group with 30 cases. Occurrence of DVT and bleeding were observed under color Doppler of lower limbs.RESULTS AND CONCLUSION: There was no statistics differences in DVT prevention and intraoperative bleeding between the two groups (P ＜ 0.05). Rivaroxaban has similar effects to low molecular weight heparin on DVT prevention after THA .关键词
利伐沙班/全髋关节置换/下肢深静脉血栓/低分子肝素/安全性分类
医药卫生引用本文复制引用
靖光武,叶树楠,杨述华..髋关节置换后利伐沙班与低分子肝素预防下肢深静脉血栓的比较[J].中国组织工程研究与临床康复,2011,15(22):4028-4031,4.
